Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes patients with major depressive disorder: a double-blind, placebo-controlled pilot study

Completed

• Conditions: Major depressive disorder; Mental and Behavioural Disorders; Depression

• Registration Number: ISRCTN30877831
• Lead Sponsor: VU University Medical Center, EMGO-Institute (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2006-04-28
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. 18 - 75 years old
2. Having diabetes
3. Current diagnosis of major depressive disorder that is being treated with ongoing anti-depressant medication
4. Signed informed consent

Exclusion Criteria

1. Psychotic features
2. History of (hypo)-mania
3. An average consumption of fish higher than two servings per week or current daily use of fish oil supplements
4. Active suicidal ideation or a history of suicide attempt
5. Allergy for fish or fish products
6. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified